These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23687288)

  • 1. The Impact of HIV Drug Resistance on the Selection of First- and Second-Line ART in Resource-Limited Settings.
    Bertagnolio S; Perno CF; Vella S; Pillay D
    J Infect Dis; 2013 Jun; 207 Suppl 2():S45-8. PubMed ID: 23687288
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings.
    Cambiano V; Bertagnolio S; Jordan MR; Lundgren JD; Phillips A
    J Infect Dis; 2013 Jun; 207 Suppl 2():S57-62. PubMed ID: 23687290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries.
    De Luca A; Hamers RL; Schapiro JM
    J Infect Dis; 2013 Jun; 207 Suppl 2():S63-9. PubMed ID: 23687291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond first-line HIV treatment regimens: the current state of antiretroviral regimens, viral load monitoring, and resistance testing in resource-limited settings.
    Kumarasamy N; Krishnan S
    Curr Opin HIV AIDS; 2013 Nov; 8(6):586-90. PubMed ID: 24100872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of HIV drug resistance during first- and second-line antiretroviral therapy in resource-limited settings.
    Hosseinipour MC; Gupta RK; Van Zyl G; Eron JJ; Nachega JB
    J Infect Dis; 2013 Jun; 207 Suppl 2(Suppl 2):S49-56. PubMed ID: 23687289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of antiretroviral resistance in children with HIV in low- and middle-income countries.
    Fitzgerald F; Penazzato M; Gibb D
    J Infect Dis; 2013 Jun; 207 Suppl 2(Suppl 2):S85-92. PubMed ID: 23687294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment.
    Bennett DE; Myatt M; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():25-36. PubMed ID: 18575189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of interrupting antiretroviral treatment before HIV drug resistance testing in patients with persistently detectable low-level viremia.
    Sirvent JL; Socas MM; Calzadilla CH; Lirola AM; Valls MR
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):111-3. PubMed ID: 16123693
    [No Abstract]   [Full Text] [Related]  

  • 11. World Health Organization generic protocol to assess drug-resistant HIV among children <18 months of age and newly diagnosed with HIV in resource-limited countries.
    Bertagnolio S; Penazzato M; Jordan MR; Persaud D; Mofenson LM; Bennett DE;
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S254-60. PubMed ID: 22544184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing HIV resistance in developing countries: Brazil as a case study.
    Petersen ML; Boily MC; Bastos FI
    Rev Panam Salud Publica; 2006 Mar; 19(3):146-56. PubMed ID: 16640843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transmission of antiretroviral drug resistant strains in patients diagnosed with human immunodeficiency virus infection in Gran Canaria in the period 2009-2012].
    Chamizo-López FJ; Gilarranz-Luengo R; Hernández-Febles M; Pena-López MJ
    Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):695-6. PubMed ID: 24666476
    [No Abstract]   [Full Text] [Related]  

  • 14. Management of Virologic Failure and HIV Drug Resistance.
    McCluskey SM; Siedner MJ; Marconi VC
    Infect Dis Clin North Am; 2019 Sep; 33(3):707-742. PubMed ID: 31255384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mutations resulting in resistence of antiretroviral drugs in HIV-infected patients].
    Cabrera C; Clotet B
    Med Clin (Barc); 2005 Apr; 124(16):618-9. PubMed ID: 15871779
    [No Abstract]   [Full Text] [Related]  

  • 16. HIV Drug Resistance - An Emerging Threat to Epidemic Control.
    Beyrer C; Pozniak A
    N Engl J Med; 2017 Oct; 377(17):1605-1607. PubMed ID: 29069566
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging antiretroviral drug resistance in sub-Saharan Africa: novel affordable technologies are needed to provide resistance testing for individual and public health benefits.
    van Zyl GU; Frenkel LM; Chung MH; Preiser W; Mellors JW; Nachega JB
    AIDS; 2014 Nov; 28(18):2643-8. PubMed ID: 25493592
    [No Abstract]   [Full Text] [Related]  

  • 18. Population-based monitoring of HIV drug resistance in Namibia with early warning indicators.
    Hong SY; Jonas A; Dumeni E; Badi A; Pereko D; Blom A; Muthiani VS; Shiningavamwe AN; Mukamba J; Andemichael G; Barbara R; Bennett DE; Jordan MR
    J Acquir Immune Defic Syndr; 2010 Dec; 55(4):27-31. PubMed ID: 20838224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of HIV drug resistance and public health implications in low- and middle-income countries.
    Bertagnolio S; De Luca A; Vitoria M; Essajee S; Penazzato M; Hong SY; McClure C; Duncombe C; Jordan MR
    Antivir Ther; 2012; 17(6):941-53. PubMed ID: 22898622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotyping external quality assurance in the World Health Organization HIV drug resistance laboratory network during 2007-2010.
    Parkin N; Bremer J; Bertagnolio S
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S266-72. PubMed ID: 22544186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.